A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1s-tied-lower-risk-psychiatric-decline-pre-existing-2026a10008cl?src=rss
Author :
Publish date : 2026-03-18 23:35:00
Copyright for syndicated content belongs to the linked Source.
